These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 21029961

  • 1. Immunologic basis of vaccine vectors.
    Liu MA.
    Immunity; 2010 Oct 29; 33(4):504-15. PubMed ID: 21029961
    [Abstract] [Full Text] [Related]

  • 2. Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.
    Ranasinghe C, Ramshaw IA.
    Expert Rev Vaccines; 2009 Sep 29; 8(9):1171-81. PubMed ID: 19722891
    [Abstract] [Full Text] [Related]

  • 3. Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses.
    Didierlaurent A, Ramirez JC, Gherardi M, Zimmerli SC, Graf M, Orbea HA, Pantaleo G, Wagner R, Esteban M, Kraehenbuhl JP, Sirard JC.
    Vaccine; 2004 Sep 03; 22(25-26):3395-403. PubMed ID: 15308364
    [Abstract] [Full Text] [Related]

  • 4. Rational design of gene-based vaccines.
    Barouch DH.
    J Pathol; 2006 Jan 03; 208(2):283-9. PubMed ID: 16362986
    [Abstract] [Full Text] [Related]

  • 5. An overview of vaccine vectors.
    Dorner F.
    Dev Biol Stand; 1995 Jan 03; 84():23-32. PubMed ID: 7796959
    [No Abstract] [Full Text] [Related]

  • 6. CD8+ T lymphocytes against mycobacterium tuberculosis.
    Klein MR, McAdam KP.
    Arch Immunol Ther Exp (Warsz); 1999 Jan 03; 47(5):313-20. PubMed ID: 10604237
    [Abstract] [Full Text] [Related]

  • 7. Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.
    Gómez CE, Nájera JL, Sánchez R, Jiménez V, Esteban M.
    Vaccine; 2009 May 21; 27(24):3165-74. PubMed ID: 19446187
    [Abstract] [Full Text] [Related]

  • 8. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J, Paoletti E.
    Prog Vet Microbiol Immunol; 1988 May 21; 4():197-217. PubMed ID: 3078866
    [Abstract] [Full Text] [Related]

  • 9. Gene-based vaccines: Recent developments.
    Liu MA.
    Curr Opin Mol Ther; 2010 Feb 21; 12(1):86-93. PubMed ID: 20140820
    [Abstract] [Full Text] [Related]

  • 10. Virology. New vaccine and treatment excite Ebola researchers.
    Enserink M.
    Science; 2003 Nov 14; 302(5648):1141-2. PubMed ID: 14615510
    [No Abstract] [Full Text] [Related]

  • 11. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M, López-Vázquez AB, de Cerio AL, Huarte E, Casares N, Prieto J, Borrás-Cuesta F, Lasarte JJ, Sarobe P.
    Scand J Immunol; 2009 Feb 14; 69(2):80-9. PubMed ID: 19144076
    [Abstract] [Full Text] [Related]

  • 12. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC, Anderson E, Bootland LM, Chiou PW, Johnson M, Kim C, Mourich D, Trobridge G.
    Dev Biol Stand; 1997 Feb 14; 90():267-77. PubMed ID: 9270855
    [Abstract] [Full Text] [Related]

  • 13. T-cell immunity generated by recombinant adenovirus vaccines.
    Yang TC, Millar JB, Grinshtein N, Bassett J, Finn J, Bramson JL.
    Expert Rev Vaccines; 2007 Jun 14; 6(3):347-56. PubMed ID: 17542750
    [Abstract] [Full Text] [Related]

  • 14. Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus.
    Jones L, Tenorio E, Gorham J, Yilma T.
    Am J Vet Res; 1997 Jun 14; 58(6):590-3. PubMed ID: 9185963
    [Abstract] [Full Text] [Related]

  • 15. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z, Charters TJ.
    Expert Rev Vaccines; 2007 Aug 14; 6(4):539-46. PubMed ID: 17669008
    [Abstract] [Full Text] [Related]

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 14; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin.
    Hsieh CJ, Kim TW, Hung CF, Juang J, Moniz M, Boyd DA, He L, Chen PJ, Chen CH, Wu TC.
    Vaccine; 2004 Sep 28; 22(29-30):3993-4001. PubMed ID: 15364449
    [Abstract] [Full Text] [Related]

  • 18. Gene delivery of vaccines for infectious disease.
    Clark KR, Johnson PR.
    Curr Opin Mol Ther; 2001 Aug 28; 3(4):375-84. PubMed ID: 11525561
    [Abstract] [Full Text] [Related]

  • 19. Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.
    Kallel H, Kamen AA.
    Biotechnol J; 2015 May 28; 10(5):741-7. PubMed ID: 25914340
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP, Doan T, Herd KA, Netter HJ, Tindle RW.
    J Virol; 2006 Apr 28; 80(8):3975-84. PubMed ID: 16571814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.